PUBCHEM ID | 5318517 |
Molecular Weight (g/mol) | 350.4 |
Molecular Formula | C20H30O5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
IUPAC Name | (3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one |
Canonical SMILES | CC12CCC(C(C1CCC(=C)C2CC=C3C(COC3=O)O)(C)CO)O |
PUBCHEM IUPAC INCHIKEY | BOJKULTULYSRAS-OTESTREVSA-N |
Solubility Level | |
Vapour Pressure |
XLOGP3 AA | 2.8 |
CACTVS TPSA | 88.677 |
BBB Level | 3 |
Absorption Level | 0 |
EXT PPB#Prediction | 1 |
AlogP98 | 2.056 |
EXT CYP2D6#Prediction | 0 |
Mouse Female FDA | Multi-Carcinogen |
Mouse Male FDA | Multi-Carcinogen |
Rat Female FDA | Single-Carcinogen |
Rat Male FDA | Single-Carcinogen |
Ames Prediction | Non-Mutagen |
Developmental / Reproductive Toxicity | |
Rat Oral LD50 | 3.89123 g/kg_body_weight |
Ocular Irritancy | None |
Hepatotoxic#Prediction | 0 |
Effected Human Genes |
Aerobic Biodegradability Prediction | Degradable |
Physical hazards | not classified |
Health hazards | |
Environmental hazards | not classified |
Serial No. | Cas No | Gene Symbol | Organism | Interaction | Interaction Actions | PubMed Id |
---|---|---|---|---|---|---|
1 | ||||||
2 | ||||||
3 |
Serial No. | Activity Name | Details | References (PubMed) | Other details EPA (U.S) | Clinical Trials (U.S. NIH) |
---|---|---|---|---|---|
1 | Anti-bacterial | 33 | 34430627 | Andrographolide | |
2 | Anti-inflammatory | 15 | 34430627 | Andrographolide | |
3 | Anti-Cancer | 2 | 34430627 | Andrographolide | |
4 | Anti-virus | 2 | 34430627 | Andrographolide |